title: Secondary hemophagocytic lymphohistiocytosis associated with meningococcemia.
authors.affiliation: Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics and Microbiology, Eskisehir, Turkey.
authors.forename: Ener Cagri
authors.initials: EC
authors.lastname: Dinleyici
authors.forename: Ozcan
authors.initials: O
authors.lastname: Bor
authors.forename: Abdurrahman
authors.initials: A
authors.lastname: Kiremitci
authors.forename: M Arif
authors.initials: MA
authors.lastname: Aksit
mesh_terms: D000293:Adolescent; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002443:Ceftriaxone / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000097:blood / Q000209:etiology* / Q000628:therapy; D008585:Meningitis, Meningococcal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008589:Meningococcal Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D010949:Plasma; D017713:Platelet Transfusion; D012121:Respiration, Artificial; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D010406:Penicillins; D014640:Vancomycin; D002443:Ceftriaxone; D003907:Dexamethasone; D004298:Dopamine